Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingda Granules
- Development stage
- Unknown
- Lead developer
- Fujian University of Traditional Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Qingda Granules is a Traditional Chinese Medicine (TCM) candidate developed by Fujian University of Traditional Chinese Medicine for the treatment of hypertension, specifically targeting the "Liver-fire Flaming Up" syndrome. The formula is primarily composed of extracts from *Scutellaria baicalensis* (Huangqin) and *Uncaria rhynchophylla* (Gouteng). It exerts its antihypertensive effects through multiple pathways, including the regulation of the renin-angiotensin-aldosterone system (RAAS), protection of the vascular endothelium, and reduction of inflammatory cytokines. Clinical studies in China have investigated its potential to lower both systolic and diastolic blood pressure while maintaining a favorable safety profile. It is often utilized as a hospital preparation in Fujian province and has undergone Phase II clinical evaluation.
- Other names
- Qingda Keli青达颗粒
02
Targets
LTCC (Voltage-gated calcium channel (L-type))ACE (Angiotensin Converting Enzyme)
Beyond the preview
Go deeper on Qingda Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qingda Granules.